Nuvasive 

$39.75
3
-$0.91-2.24% Thursday 20:00

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
2.07B
本益比
-107.61
股息殖利率
-
股息
-

財報

7Nov預期
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0.39
0.45
0.5
0.56
預期EPS
0.5384
實際EPS
不適用

財務

3.36%利潤率
有盈利
2017
2018
2019
2020
2021
2022
1.2B營收
40.41M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 NUVA 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
執行長
J. Christopher Barry
員工
2900
國家
US
ISIN
US6707041058
WKN
000A0CAYR

上市

0 Comments

分享你的想法

FAQ

Nuvasive 今天的股價是多少?
NUVA 目前價格為 $39.75 USD,過去 24 小時下跌了 -2.24%。在圖表上更密切關注 Nuvasive 股票的表現。
Nuvasive 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Nuvasive 的股票以代號 NUVA 進行交易。
Nuvasive 的市值是多少?
今天 Nuvasive 的市值為 2.07B
Nuvasive 去年的營收是多少?
Nuvasive 去年的營收為 1.2BUSD。
Nuvasive 去年的淨利是多少?
NUVA 去年的淨收益為 40.41MUSD。
Nuvasive 有多少名員工?
截至 April 10, 2026,公司共有 2,900 名員工。
Nuvasive 位於哪個產業?
Nuvasive從事於Manufacturing產業。
Nuvasive 何時完成拆股?
Nuvasive 最近沒有進行任何拆股。
Nuvasive 的總部在哪裡?
Nuvasive 的總部位於 US 的 San Diego。